NCT06371014View on ClinicalTrials.gov

Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy

NANot yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 31, 2024

Conditions

To Analyze and Compare the Efficacy and Safety of Ondansetron and Tablet for the Prevention of Moderate and Hypoemetic Chemotherapy

Interventions

DRUG

Ondansetron oral membrane

A new oral film formulation of ondansetron was used to replace traditional tablets in the treatment of antiemetic chemotherapy

All Listed Sponsors

lead

Shanghai Children's Medical Center

OTHER

NCT06371014 - Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy | Biotech Hunter | Biotech Hunter